文献速递血管炎

抗中性粒细胞胞质抗体相关性血管炎的数据驱动亚分类:基于联邦国际队列的模型聚类分析

Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort.
PubMed 文献 · Lancet Rheumatol · 2024-08-22

基于六个欧洲血管炎登记处共3868例ANCA相关性血管炎患者,采用模型聚类分析17个混合型临床变量,识别出5个表型、生化表现和结局各异的聚类。与基于临床诊断或ANCA状态的分类相比,聚类分配模型对患者生存和肾脏生存的预测能力更优。

要点

  • 共识别5个聚类:严重肾脏受累聚类(SK,14.3%)、MPO-ANCA阳性肾脏受累聚类(MPO-K,20.2%)、PR3-ANCA阳性肾脏受累聚类(PR3-K,17.7%)、炎症多系统疾病聚类(IMS,31.1%)和以耳鼻喉受累为主的年轻患者聚类(YR,16.7%)。
  • 聚类分配模型对患者生存和肾脏生存的预测能力优于基于临床诊断或ANCA状态的模型。
  • ANCA相关性血管炎并非简单的二元结构,数据驱动亚分类对关键结局具有更高预测价值。

核心结论

  • ANCA相关性血管炎并非仅为二元结构,数据驱动亚分类对关键结局的预测价值高于当前方法。

研究设计与样本

  • FAIRVASC协作数据复用项目,从六个欧洲血管炎登记处检索ANCA相关性血管炎患者记录,对17个混合型临床变量采用简约双潜高斯变量混合模型进行基于模型的聚类。
  • 共纳入1966年11月1日至2023年3月1日期间诊断的3868例ANCA相关性血管炎患者(捷克登记处371例、FVSG 1780例、GeVas 135例、POLVAS 792例、RKD 439例、Skåne血管炎队列351例)。
  • 通过聚类的人口学、表型和血清学特征及结局汇总统计进行临床验证,并将含聚类归属的模型与基于临床诊断和ANCA特异性的分类进行预测价值比较。

主要发现

  • 共2434例(62.9%)为GPA,1434例(37.1%)为MPA;诊断时平均年龄57.2岁(SD 16.4);3867例中男性2006例(51.9%),女性1861例(48.1%)。
  • 识别出5个聚类:SK聚类555例(14.3%),CRP和血清肌酐浓度高,ANCA特异性可变;MPO-K聚类782例(20.2%),肾外病变局限;PR3-K聚类683例(17.7%),肾外病变广泛。
  • IMS聚类1202例(31.1%),以PR3-ANCA阳性为主,炎症多系统疾病;YR聚类646例(16.7%),以耳鼻喉受累为主、CRP低,主要为年轻患者。
  • 与基于临床诊断或ANCA状态的模型相比,聚类分配模型对患者生存和肾脏生存的预测能力均提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a heterogenous autoimmune disease. While traditionally stratified into two conditions, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), the subclassification of ANCA-associated vasculitis is subject to continued debate. Here we aim to identify phenotypically distinct subgroups and develop a data-driven subclassification of ANCA-associated vasculitis, using a large real-world dataset. METHODS: In the collaborative data reuse project FAIRVASC (Findable, Accessible, Interoperable, Reusable, Vasculitis), registry records of patients with ANCA-associated vasculitis were retrieved from six European vasculitis registries: the Czech Registry of ANCA-associated vasculitis (Czech Republic), the French Vasculitis Study Group Registry (FVSG; France), the Joint Vasculitis Registry in German-speaking Countries (GeVas; Germany), the Polish Vasculitis Registry (POLVAS; Poland), the Irish Rare Kidney Disease Registry (RKD; Ireland), and the Skåne Vasculitis Cohort (Sweden). We performed model-based clustering of 17 mixed-type clinical variables using a parsimonious mixture of two latent Gaussian variable models. Clinical validation of the optimal cluster solution was made through summary statistics of the clusters' demography, phenotypic and serological characteristics, and outcome. The predictive value of models featuring the cluster affiliations were compared with classifications based on clinical diagnosis and ANCA specificity. People with lived experience were involved throughout the FAIRVASVC project. FINDINGS: A total of 3868 patients diagnosed with ANCA-associated vasculitis between Nov 1, 1966, and March 1, 2023, were included in the study across the six registries (Czech Registry n=371, FVSG n=1780, GeVas n=135, POLVAS n=792, RKD n=439, and Skåne Vasculitis Cohort n=351). There were 2434 (62·9%) patients with GPA and 1434 (37·1%) with MPA. Mean age at diagnosis was 57·2 years (SD 16·4); 2006 (51·9%) of 3867 patients were men and 1861 (48·1%) were women. We identified five clusters, with distinct phenotype, biochemical presentation, and disease outcome. Three clusters were characterised by kidney involvement: one severe kidney cluster (555 [14·3%] of 3868 patients) with high C-reactive protein (CRP) and serum creatinine concentrations, and variable ANCA specificity (SK cluster); one myeloperoxidase (MPO)-ANCA-positive kidney involvement cluster (782 [20·2%]) with limited extrarenal disease (MPO-K cluster); and one proteinase 3 (PR3)-ANCA-positive kidney involvement cluster (683 [17·7%]) with widespread extrarenal disease (PR3-K cluster). Two clusters were characterised by relative absence of kidney involvement: one was a predominantly PR3-ANCA-positive cluster (1202 [31·1%]) with inflammatory multisystem disease (IMS cluster), and one was a cluster (646 [16·7%]) with predominantly ear-nose-throat involvement and low CRP, with mainly younger patients (YR cluster). Compared with models fitted with clinical diagnosis or ANCA status, cluster-assigned models demonstrated improved predictive power with respect to both patient and kidney survival. INTERPRETATION: Our study reinforces the view that ANCA-associated vasculitis is not merely a binary construct. Data-driven subclassification of ANCA-associated vasculitis exhibits higher predictive value than current approaches for key outcomes. FUNDING: European Union's Horizon 2020 research and innovation programme under the European Joint Programme on Rare Diseases.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gisslander K, White A, Aslett L, et al. Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort. Lancet Rheumatol. 2024. PMID: 39182506. doi:10.1016/S2665-9913(24)00187-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。